TBPH vs GILD: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Gilead Sciences Inc in 2026
TBPH
Theravance Biopharma Inc
$17.23
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | TBPH | GILD | Winner |
|---|---|---|---|
| Market Cap | $864.05M | $171.97B | GILD |
| P/E Ratio | 8.15 | 20.44 | TBPH |
| EPS (TTM) | $2.06 | $6.78 | GILD |
| Revenue Growth | 1.4% | 0.0% | TBPH |
| Gross Margin | 65.2% | 78.8% | GILD |
Analyze TBPH
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or GILD a better investment?
Comparing TBPH and GILD: Theravance Biopharma Inc has a market cap of $864.05M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and GILD?
TBPH (Theravance Biopharma Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or GILD?
Based on P/E ratios, TBPH trades at a lower multiple (8.1x vs 20.4x).
Which is growing faster: TBPH or GILD?
TBPH has higher revenue growth at 1.4% vs 0.0% for GILD.
Which company is more profitable: TBPH or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 65.2% for TBPH.
Which is the larger company: TBPH or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $864.05M for TBPH.
Should I buy TBPH or GILD in 2026?
Both TBPH and GILD have investment merit. TBPH trades at $17.23 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and GILD stock?
Key differences: Market Cap ($864.05M vs $171.97B), P/E Ratio (8.1x vs 20.4x), Revenue Growth (1.4% vs 0.0%), Gross Margin (65.2% vs 78.8%).